|
|
FOR IMMEDIATE RELEASE
September 06, 2006
|
 |
|
ADVAMED STATEMENT ON DR. MARK MCCLELLAN’S DEPARTURE FROM CMS
|
Washington, D.C. – In response today to the resignation of Dr. Mark McClellan, Administrator of the Centers for Medicare and Medicaid Services (CMS), AdvaMed President and CEO, Stephen J. Ubl, issued the following statement:
“Mark’s leadership at the White House, the FDA and CMS on the most pressing healthcare issues facing patients will leave a lasting impact. His role in the early stages of the `Critical Path Initiative’ at FDA and the development and implementation of a new and improved Medicare program with greater emphasis on prevention and quality of care are important legacies that he leaves behind. We will miss working with Mark but we look forward to his continued leadership on health care issues.”
AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. Our members produce nearly 90 percent of the health care technology purchased annually in the United States and more than 50 percent purchased annually around the world. AdvaMed members range from the largest to the smallest medical technology innovators and companies.
###
|